We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Worldwide POC Diagnostics Market to Grow

By Labmedica staff writers
Posted on 07 Aug 2006
Print article
The worldwide point-of-care (POC) diagnostics market is about to undergo exceptional growth, according to a new report compiled by Cambridge Consultants (Cambridge Science Park, UK).

The report was released following a workshop held in May 2006 by Cambridge Consultants. The participants, who came from across the diagnostics industry, discussed the future of point-of-care testing (POCT) and the role of technology. Attending the 24-hour workshop were delegates from a variety of backgrounds, including clinicians and representatives of diagnostic companies.

Increased availability of accurate, rapid tests, patient demand for instant results, integration with drug delivery technology, and a general shift from lab-based tests to testing in the home, in doctor's surgeries, and over the pharmacy counter were the reasons given for the expected increase in the POCT domestic market.

The delegates questioned whether the technology was adequate. They agreed that the current wet chemistry used in diagnostic testing is adequate and that the barriers to faster adoption lie in post-test data management and quality control. However, the delegation also agreed that new and emerging technologies, such as micro- and nano-technology and novel labels, could revolutionize POCT and diagnostic testing in the future. The group felt that in the meantime those in the industry need to work together to enable doctors and patients to collate the results of the tests. In addition, standardization is necessary to speed adoption of POCT technology, as well as to provide the patient with a common user interface.

The market for POCT differs from region to region. In the United States, defensive medicine dominates, and concerns over liability means that a final confirmatory central test is required. In Europe, adoption depends on clinical benefits and centralized purchasing, and the rate of acceptance is different within each country. In countries like Sweden and Germany, which have decentralized health services, POCT uptake is moving fast with high awareness among doctors and patients. The United Kingdom's difficulty in employing information technology (IT) on time and within budget suggests that countries with similar centralized health services might struggle with POCT adoption.

"Diagnostics could learn a lot from the phone industry,” said Dr. Burnell, diagnostics campaign manager at Cambridge Consultants. "As a group they came together to focus on standardizing aspects of their technology as they realized that this would benefit the customer, as well as the companies who were then free to innovate and add value. The diagnostics industry needs to follow suit and work out a way of providing data from point-of-care devices in a simple and common format.”



Related Links:
Cambridge Consultants
Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.